Saravanaraman Ponne

Dr. Saravanaraman Ponne

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2018
Verified
Book Chapter
Open access
PDF file
LSLoudu Srijyothi
Loudu Srijyothi
SPSaravanaraman Ponne
Saravanaraman Ponne
TPTalukdar Prathama
Talukdar Prathama
CACheemala Ashok
Cheemala Ashok
SBSudhakar Baluchamy
Sudhakar Baluchamy
Non-coding RNAs (ncRNAs) are functional RNA molecules that are transcribed from mammalian genome but lack protein coding capacity. Nearly 80% of the human genome constitutes non-coding elements such as small non-coding RNAs, sncRNAs (miRNA, piRNA, SiRNA, SnRNA) and long non-coding RNAs, lncRNAs (linc RNA, NAT, eRNA, circ RNA, ceRNAs, PROMPTS). These ncRNAs have been extensively studied and are known to mediate the regulation of gene expression. In recent decades, lncRNAs have emerged as pivotal molecules that participate in the post-transcriptional regulation by acting as a signal, guide, scaffold and decoy molecules in addition to their role(s) in transcription. ncRNAs are known to play critical roles in defining DNA methylation patterns, imprinting as well as chromatin remodeling, thus having a substantial effect in epigenetic signaling. The expression of lncRNAs is regulated in a tissue specific and developmental stage specific manner and their mis-regulation is often associated with tumorigenesis. Henceforth, this chapter focuses mainly on the role(s) of ncRNAs in transcriptional and post-transcriptional regulation and their relevance in cancers.

5 November 2019 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
SPSaravanaraman Ponne
Saravanaraman Ponne
CKChinnadurai Raj Kumar
Chinnadurai Raj Kumar
RBRathanam Boopathy
Rathanam Boopathy

23 March 2024 in Vaccine
Verified
Journal Article
Closed access
SPSaravanaraman Ponne
Saravanaraman Ponne
RKRajender Kumar
Rajender Kumar
SVS.M. Vanmathi
S.M. Vanmathi
RBRaimunda Sâmia Nogueira Brilhante
Raimunda Sâmia Nogueira Brilhante
CKChinnadurai Raj Kumar
Chinnadurai Raj Kumar

6 January 2026 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
DCDavid Jefrey Christo
David Jefrey Christo
AMAman Kumar Mohanty
Aman Kumar Mohanty
SPSaravanaraman Ponne
Saravanaraman Ponne
PMPraveen Manoharan
Praveen Manoharan
RCRaj Kumar Chinnadurai
Raj Kumar Chinnadurai

13 July 2026 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SMSelvamani M
Selvamani M
SNSwapna N
Swapna N
IOIyappan Ramalakshmi Oviya
Iyappan Ramalakshmi Oviya
JRJawahar R
Jawahar R
IGIrisappan Ganesh
Irisappan Ganesh
SPSaravanaraman Ponne
Saravanaraman Ponne
PWWP2A and PWWP2B are chromatin-binding proteins that play a significant role by recognizing methylated histone tails, H3K36me3. Their genetic variants are less characterized when compared to other chromatin-binding proteins. Out of the 1123 and 1300 SNPs reported for the PWWP2A and PWWP2B in Ensemble and dbSNP databases, 13 nsSNPs in the PWWP domain of PWWP2A and 8 in PWWP2B were prioritized for investigation. It was observed that most of these residues are in a buried region of the PWWP domain, and any substitution might result in the loss of interactions in the hydrophobic core and compromise overall domain integrity. Additionally, the gained hydrogen bonds were found to be unlikely in compensating the native interactions; instead, they act as stabilizing ones. Docking and structural analyses further demonstrated that substitutions within the aromatic cage and its peripheral loop regions predominantly destabilize the PWWP fold and remodel the interaction interface, providing a mechanistic explanation for impaired chromatin recognition. Such structural perturbations are likely to alter the electrostatic and hydrophobic properties of the binding surface, thereby weakening histone mark recognition and reducing chromatin-binding efficiency. Especially variants such as W695R and T700A in PWWP2A, and T536M and D492G/H in PWWP2B, appear to be potential candidates for further investigation because these substitutions consistently showed distinct structural deviations across multiple analyses. Considering the detrimental effects of these nsSNPs, this study prioritizes them for experimental validation to confirm their role in disease, as they have a high likelihood to disrupt PWWP domain-mediated interactions and reduce chromatin-binding efficiency.